Effects of heparin and enoxaparin on APP processing and Aβ production in primary cortical neurons from Tg2576 mice.
<h4>Background</h4>Alzheimer's disease (AD) is caused by accumulation of Aβ, which is produced through sequential cleavage of β-amyloid precursor protein (APP) by the β-site APP cleaving enzyme (BACE1) and γ-secretase. Enoxaparin, a low molecular weight form of the glycosaminoglycan...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eda00fd627b64d1b93cb1126837c49bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:eda00fd627b64d1b93cb1126837c49bd |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:eda00fd627b64d1b93cb1126837c49bd2021-11-18T06:48:58ZEffects of heparin and enoxaparin on APP processing and Aβ production in primary cortical neurons from Tg2576 mice.1932-620310.1371/journal.pone.0023007https://doaj.org/article/eda00fd627b64d1b93cb1126837c49bd2011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21829577/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Alzheimer's disease (AD) is caused by accumulation of Aβ, which is produced through sequential cleavage of β-amyloid precursor protein (APP) by the β-site APP cleaving enzyme (BACE1) and γ-secretase. Enoxaparin, a low molecular weight form of the glycosaminoglycan (GAG) heparin, has been reported to lower Aβ plaque deposition and improve cognitive function in AD transgenic mice.<h4>Methodology/principal findings</h4>We examined whether heparin and enoxaparin influence APP processing and inhibit Aβ production in primary cortical cell cultures. Heparin and enoxaparin were incubated with primary cortical cells derived from Tg2576 mice, and the level of APP and proteolytic products of APP (sAPPα, C99, C83 and Aβ) was measured by western blotting. Treatment of the cells with heparin or enoxaparin had no significant effect on the level of total APP. However, both GAGs decreased the level of C99 and C83, and inhibited sAPPα and Aβ secretion. Heparin also decreased the level of β-secretase (BACE1) and α-secretase (ADAM10). In contrast, heparin had no effect on the level of ADAM17.<h4>Conclusions/significance</h4>The data indicate that heparin and enoxaparin decrease APP processing via both α- and β-secretase pathways. The possibility that GAGs may be beneficial for the treatment of AD needs further study.Hao CuiAmos C HungDavid W KlaverToshiharu SuzukiCraig FreemanChristian NarkowiczGlenn A JacobsonDavid H SmallPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 7, p e23007 (2011) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Hao Cui Amos C Hung David W Klaver Toshiharu Suzuki Craig Freeman Christian Narkowicz Glenn A Jacobson David H Small Effects of heparin and enoxaparin on APP processing and Aβ production in primary cortical neurons from Tg2576 mice. |
description |
<h4>Background</h4>Alzheimer's disease (AD) is caused by accumulation of Aβ, which is produced through sequential cleavage of β-amyloid precursor protein (APP) by the β-site APP cleaving enzyme (BACE1) and γ-secretase. Enoxaparin, a low molecular weight form of the glycosaminoglycan (GAG) heparin, has been reported to lower Aβ plaque deposition and improve cognitive function in AD transgenic mice.<h4>Methodology/principal findings</h4>We examined whether heparin and enoxaparin influence APP processing and inhibit Aβ production in primary cortical cell cultures. Heparin and enoxaparin were incubated with primary cortical cells derived from Tg2576 mice, and the level of APP and proteolytic products of APP (sAPPα, C99, C83 and Aβ) was measured by western blotting. Treatment of the cells with heparin or enoxaparin had no significant effect on the level of total APP. However, both GAGs decreased the level of C99 and C83, and inhibited sAPPα and Aβ secretion. Heparin also decreased the level of β-secretase (BACE1) and α-secretase (ADAM10). In contrast, heparin had no effect on the level of ADAM17.<h4>Conclusions/significance</h4>The data indicate that heparin and enoxaparin decrease APP processing via both α- and β-secretase pathways. The possibility that GAGs may be beneficial for the treatment of AD needs further study. |
format |
article |
author |
Hao Cui Amos C Hung David W Klaver Toshiharu Suzuki Craig Freeman Christian Narkowicz Glenn A Jacobson David H Small |
author_facet |
Hao Cui Amos C Hung David W Klaver Toshiharu Suzuki Craig Freeman Christian Narkowicz Glenn A Jacobson David H Small |
author_sort |
Hao Cui |
title |
Effects of heparin and enoxaparin on APP processing and Aβ production in primary cortical neurons from Tg2576 mice. |
title_short |
Effects of heparin and enoxaparin on APP processing and Aβ production in primary cortical neurons from Tg2576 mice. |
title_full |
Effects of heparin and enoxaparin on APP processing and Aβ production in primary cortical neurons from Tg2576 mice. |
title_fullStr |
Effects of heparin and enoxaparin on APP processing and Aβ production in primary cortical neurons from Tg2576 mice. |
title_full_unstemmed |
Effects of heparin and enoxaparin on APP processing and Aβ production in primary cortical neurons from Tg2576 mice. |
title_sort |
effects of heparin and enoxaparin on app processing and aβ production in primary cortical neurons from tg2576 mice. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2011 |
url |
https://doaj.org/article/eda00fd627b64d1b93cb1126837c49bd |
work_keys_str_mv |
AT haocui effectsofheparinandenoxaparinonappprocessingandabproductioninprimarycorticalneuronsfromtg2576mice AT amoschung effectsofheparinandenoxaparinonappprocessingandabproductioninprimarycorticalneuronsfromtg2576mice AT davidwklaver effectsofheparinandenoxaparinonappprocessingandabproductioninprimarycorticalneuronsfromtg2576mice AT toshiharusuzuki effectsofheparinandenoxaparinonappprocessingandabproductioninprimarycorticalneuronsfromtg2576mice AT craigfreeman effectsofheparinandenoxaparinonappprocessingandabproductioninprimarycorticalneuronsfromtg2576mice AT christiannarkowicz effectsofheparinandenoxaparinonappprocessingandabproductioninprimarycorticalneuronsfromtg2576mice AT glennajacobson effectsofheparinandenoxaparinonappprocessingandabproductioninprimarycorticalneuronsfromtg2576mice AT davidhsmall effectsofheparinandenoxaparinonappprocessingandabproductioninprimarycorticalneuronsfromtg2576mice |
_version_ |
1718424389288984576 |